Sotorasib’s Confirmatory Data in NSCLC Unreliable, Says FDA Panel
An FDA advisory committee on Thursday said the confirmatory trial data for the…
Browsing Tag
NSCLC
Non-small Cell Lung Cancer Market is Projected to Boost by 2032, Predicts…
New York, USA, July 27, 2023 (GLOBE NEWSWIRE) -- Non-small Cell Lung Cancer Market is Projected to Boost by 2032, Predicts DelveInsight | Key Companies Working in Space - AstraZeneca,…
Immunotherapy Added to SABR Improves Event-Free Survival in Early NSCLC
Stereotactic ablative radiotherapy (SABR) combined with immunotherapy (I-SABR)…
Some NSCLC Patients on ICI Therapy Fare Worse With Proton Pump Inhibitor Use
Proton pump inhibitor (PPI) use was independently associated with worse…
Adjuvant Osimertinib as a Standard Therapy for EGFR-Positive NSCLC
Treatment with osimertinib (Tagrisso) after surgery significantly reduced the risk of death…
8.2% CAGR for Lung Cancer Screening Market Worth $4.36Bn by 2030 with NSCLC Segment…
Pune, India, July 06, 2023 (GLOBE NEWSWIRE) -- According to Recently Published Report by The Insight Partners, “Lung Cancer Screening Market Size Report and Forecast to 2030 - COVID-19…
Adjuvant Immunotherapy in Early-Stage NSCLC
Adjuvant chemotherapy has been the standard of care for patients with resectable non-small…
Zai Lab Announces NDA Acceptance of Repotrectinib for Patients with ROS1-positive…
SHANGHAI, China and CAMBRIDGE, Mass., June 28, 2023 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that the National Medical Products Administration (NMPA)…
The Role of Immunotherapy in Early-Stage NSCLC
At the American Society of Clinical Oncology (ASCO) annual meeting, several positive trials…
TTFields Therapy Yields OS Improvement in Second-Line NSCLC
CHICAGO -- Treatment with tumor treating field (TTFields) therapy combined with standard of care improved overall…